Correction to: Integrity of dural closure after autologous platelet rich fibrin augmentation: an in vitro study
-
By
-
I. Vasilikos
-
J. Beck
-
S. Ghanaati
-
J. Grauvogel
-
T. Nisyrios
-
K. Grapatsas
-
U. Hubbe
-
September 3, 2021
-
Clinical Scorecard: Evaluation of Dural Closure Integrity Following Augmentation with Autologous Platelet-Rich Fibrin: An In Vitro Investigation
At a Glance
| Category | Detail |
|---|
| Condition | Dural closure integrity post-neurosurgical procedures |
| Key Mechanisms | Augmentation of dural closure using autologous platelet-rich fibrin to enhance sealing |
| Target Population | Patients undergoing neurosurgical procedures requiring dural closure |
| Care Setting | Neurosurgical operative and postoperative care settings |
Key Highlights
- Study evaluates the effectiveness of autologous platelet-rich fibrin in reinforcing dural closure.
- In vitro investigation provides insights into the sealing integrity after augmentation.
- Findings support potential benefits of platelet-rich fibrin in neurosurgical dural repair.
Guideline-Based Recommendations
Diagnosis
- Assessment of dural closure integrity should be considered post-neurosurgery.
Management
- Consider augmentation of dural closure with autologous platelet-rich fibrin to improve sealing.
Monitoring & Follow-up
- Monitor for signs of cerebrospinal fluid leakage postoperatively.
Risks
- Potential risks related to dural closure failure include cerebrospinal fluid leaks and associated complications.
Patient & Prescribing Data
Patients undergoing neurosurgical procedures involving dural repair
Autologous platelet-rich fibrin may enhance dural closure integrity, potentially reducing postoperative complications.
Clinical Best Practices
- Utilize autologous platelet-rich fibrin as an adjunct to standard dural closure techniques when appropriate.
- Ensure meticulous surgical technique to optimize dural closure integrity.
- Implement postoperative monitoring protocols for early detection of dural closure failure.
References
